Oral Presentation 36th TROG Cancer Research Annual Scientific Meeting 2024

The GETUG Strategy of clinical trials in oligometastatic prostate cancer (#19)

Stéphane SUPIOT 1
  1. Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, --- SELECT ONE ---, France

The GETUG Strategy of clinical trials in oligometastatic prostate cancer